Abstract
Rationale
Prepulse inhibition (PPI) of the startle response is a classic model of sensorimotor gating. Robust PPI impairments can be induced by dopamine agonists such as the indirect agonist amphetamine. The antipsychotic clozapine can attenuate PPI impairment induced by dopamine agonists. Clozapine is a complex drug with antagonistic effects on a variety of receptors, including serotonin and histamine. The relative contribution of its component actions to its efficacy is still unclear.
Objectives
To better characterize the role of histamine and serotonin receptors in the modulation of PPI in rats, we studied the effects of the H1 histamine antagonist pyrilamine (10, 20, and 40 mg/kg) on amphetamine-induced (1 mg/kg) PPI deficits (Experiment 1); and the interaction of pyrilamine (20 mg/kg) with the 5-HT2 antagonist ketanserin (1 and 2 mg/kg) on the amphetamine-induced PPI disruption (Experiment 2).
Methods
Tactile startle stimuli consisted of 30 PSI air-puffs. Three acoustic prepulse intensity levels were used: 68, 71, and 77 dB, presented on a 65-dB background noise. In both experiments, all animals received all drug doses and combinations with different counterbalanced orders.
Results
Pyrilamine (20 mg/kg) was effective in counteracting the PPI impairment caused by amphetamine administration, whereas ketanserin exacerbated the amphetamine-induced PPI deficit.
Conclusions
Based on its ability to reverse amphetamine-induced PPI deficits, blockade of histamine H1 receptors seems to contribute to the therapeutic effect of the antipsychotic clozapine. Serotonin 5-HT2-receptor blockade, though, does not appear to contribute to this effect, and may in fact detract from it.
Similar content being viewed by others
References
Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787–794
Bortolato M, Aru GN, Fa M, Frau R, Orru M, Salis P et al (2005) Activation of D1, but not D2 receptor potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Neuropsychopharmacol 30:561–574
Braff DL, Stone C, Callaway E, Geyer MA, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–343
Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patients groups, and pharmacological studies. Psychopharmacology 156:234–258
Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, Fox GB (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153:69–76
Bubenikova T, Votava M, Horacek J, Palenicek T, Dockery C (2005) The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav 80:591–596
Caceda R, Kinkead B, Owens MJ, Nemeroff CB (2005) Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation. J Neurosci 25:11748–11756
Classen W, Laux G (1988) Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry 21:295–297
Conti LH, Costill JE, Flynn S, Tayler JE (2005) Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotrophin-releasing factor and by rat strain. Behav Neurosci 119:1052–1060
Coward DM (1992) General pharmacology of clozapine. Brit J Psychiat 160:5–11
Dai H, Okuda T, Sakurai E, Kuramasu A, Kato M, Jia G et al (2005) Blockage of histamine H1 receptor attenuates social isolation-induced disruption of prepulse inhibition: a study in H1 receptor gene knockout mice. Psychopharmacology 183:285–293
De Belleroche JS, Gardiner IM (1982) Contrasting effects of 5-hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat. J Neural Transm 55:227–242
Galosi R, Lenard L, Knoche A, Haas H, Huston JP, Schwarting RKW (2001) Dopaminergic effects of histamine administration in the nucleus accumbens and the impact of H1-receptor blockade. Neuropharmacology 40:624–633
Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154
Geyer MA, Krebs-Thomson K, Varty GB (1999) The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia. Neuropsychopharmacol 21:S134–S142
Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D et al (1993) The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Brit J Psychiat 162:43–48
Graham FK (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238–248
Guan XM, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541–547
Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 43:269–282
Johansson C, Jackson DM, Zhang J, Svensson L (1995) Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav 52:649–654
Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107–128
Kumari V, Sharma T (2002) Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology 162:97–101
Le Pen G, Moreau JL (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacol 27:1–11
Levin ED, Caldwell DP, Perraut C (2007) Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol Biochem Behav 86:597–605
Levin ED, Perkins A, Brotherton T, Qazi M, Berez C, Montalvo-Ortiz J, Davis K, Williams P, Christopher NC (2009) Chronic underactivity of medial frontal cortical β2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats. Prog Neuro-Psychopharmacol 33:296–302
Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacol 2:299–308
Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507–514
McGurk SR (1999) The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 60:24–29
Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bull 25:233–256
Onodera K, Yamatodani A, Watanabe T, Wada H (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42:685–702
Panula P, Yang HYT, Costa E (1984) Histamine containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572–2576
Pocivavsek A, Icenogle L, Levin ED (2006) Hippocampal α7 and α4β2 nicotinic receptors and clozapine effects on memory. Psychopharmacology 188:596–604
Roegge CS, Perraut C, Hao X, Levin ED (2007) Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav 86:686–692
Schwarzkopf SB, Bruno JP, Mitrab T (1993) Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions. Prog Neuro-Psychopharmacol 17:1023–1036
Sills TL (1999) Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res Bull 48:445–448
Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441–448
Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Iowa
Sutherland JE, Page ME, Conti LH (2008) The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav 89:324–337
Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741–744
Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298–301
Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 58:182–200
Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM (2005) Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol Biochem Behav 80:203–211
Tenn CC, Fletcher PJ, Kapur SA (2005) A putative animal model of the “prodronal” state of schizophrenia. Biol Psychiatry 57:586–593
Varty GB, Higgins GA (1995) Reversal of a dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin. Eur J Pharmacol 287:201–205
Wan FJ, Swerdlow NR (1993) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113:103–109
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larrauri, J.A., Levin, E.D. PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin. Psychopharmacology 212, 551–558 (2010). https://doi.org/10.1007/s00213-010-2005-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-2005-6